Article Information
History
- July 18, 2022.
Article Versions
- Version 1 (May 26, 2022 - 15:39).
- Version 2 (July 14, 2022 - 07:18).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Saba A Qasmieh1,2,
- McKaylee M Robertson1,2,
- Chloe A Teasdale1,2,
- Sarah G Kulkarni1,
- Heidi Jones1,2,
- David A. Larsen3,
- John J. Dennehy4,
- Margaret McNairy1,5,
- Luisa N. Borrell2 and
- Denis Nash1,2,*
- 1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, NY, USA
- 2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York, NY, USA
- 3Department of Public Health, Falk College, Syracuse University, Syracuse, NY, USA
- 4Department of Biology, Queens College, City University of New York, Queens, NY, USA
- 5Center for GLobal Health and Division of General Internal Medicine, Weill Cornell Medicine, New York, NY, USA
- ↵*Correspondence to: Denis Nash, PhD, MPH, Department of Epidemiology and Biostatistics, Graduate School of Public Health and Institute of Implementation Science in Population Health, City University of New York, New York, NY. Email: denis.nash{at}sph.cuny.edu.
Posted July 18, 2022.
The prevalence of SARS-CoV-2 infection and other public health outcomes during the BA.2/BA.2.12.1 surge, New York City, April-May 2022
